How to Reset Circadian RhythmBehaviour, Mechanism, and Peptide Research

Circadian reset is not a sleep hack. It is the re-alignment of a master oscillator — roughly 20,000 neurons in the suprachiasmatic nucleus — with the peripheral clocks distributed across liver, gut, muscle, and adipose tissue. When these oscillators are coherent, hormone release, immune cycling, DNA repair, and metabolic switching fire in the correct sequence. When they drift apart, the same inputs — training, nutrition, even well-chosen compounds — land on a system that cannot use them properly.

The behavioural anchors — morning light, consistent wake time, feeding-window discipline — are the primary intervention and where most people should start. For those who have the behaviour dialled in and still struggle, five compounds act directly on the clock and its sleep architecture:

• VIP — synchronises the master oscillator
• Selank — opens the anxiety gate that blocks the clock's sleep signal
• DSIP — deepens the slow-wave architecture the clock produces
• Pinealon — protects the neural tissue that runs it
• Epitalon — restores pineal melatonin production as a periodic maintenance course

Jump to protocol →

Why Clocks Break

The SCN oscillates in isolation even without external input. Circadian failure is rarely a broken clock — it is a problem in the connections between the clock and everything it coordinates. Four patterns account for most disruption.

Weak Input Signal

Insufficient light contrast between day and night. Erratic food timing drifting peripheral clocks. Indoor living at 200–500 lux when the SCN needs 10,000+ to set the cortisol awakening response.² The clock is functional; it is receiving a weak, noisy input. This is the failure mode that behaviour alone fixes.

Phase Misalignment

The clock runs but at the wrong time. Late chronotype colliding with a 07:00 alarm. Jet lag. Shift work. Shifting wake time by two hours on a weekend produces the equivalent of transmeridian travel, and the clock spends 48 hours recovering.⁴ VIP and timed light address phase directly; Epitalon targets age-related phase drift where pineal output has declined.

Anxiety Override

The clock signals sleep descent. The nervous system vetoes it. The subjective experience is "tired but wired" — exhausted by 22:00, alert at midnight, crushed at 07:00. No amount of sleep hygiene addresses this if the underlying hyperarousal is unmanaged. The clock is fine. The gate between clock output and sleep execution is blocked. Selank opens it.

Architecture Degradation

The gate is open, but the sleep it produces is shallow. Slow-wave stages don't develop properly — either from somatic causes (pain, reflux, gut inflammation fragmenting architecture) or from endogenous decline in the delta-sleep signalling system. DSIP restores architecture. Pinealon protects the neural infrastructure that maintains it long-term.

If your circadian problem involves persistent fatigue, low cellular energy, or a pattern where sleep never feels restorative regardless of duration, the mitochondrial peptide stack addresses the energetic side. That is a body problem with a clock symptom — different compounds, different article.

Behavioural Foundation

Non-negotiable. No compound compensates for chaotic light and food timing.

• Fixed wake time within ±30 minutes, including weekends
• Morning outdoor light for 10–15 minutes within the first hour of waking — glass filters the entraining spectrum; ten minutes outside exceeds an hour under indoor fluorescents²
• Consistent feeding window compressed to 8–10 hours — the specific window matters less than its regularity³
• Caffeine cutoff 8+ hours before target sleep time
• Screen and light reduction 2–3 hours before bed
• Room temperature 18–20°C

These carry the strongest evidence base of any circadian intervention: multiple large human studies, well-characterised mechanisms, decades of replication.²˒³˒⁴ For most people, these alone are sufficient. Two to three weeks of consistent behaviour is a reasonable trial before adding compounds. Most individuals notice improved sleep onset within three to seven days; full re-alignment typically requires two to four weeks.⁴

The Circadian Stack

Four compounds that act directly on the clock and the sleep architecture it produces. They are not interchangeable — each addresses a different layer of clock function.

VIP — Master Clock Synchronisation

VIP (vasoactive intestinal peptide) synchronises the firing of SCN neurons and coordinates circadian signalling between the master clock and peripheral systems, particularly the gut-immune interface.¹⁶˒¹⁷

In the circadian context, VIP reinforces the morning peak — stabilising the day-night boundary from the top of the hierarchy. Research protocols describe 25–50 mcg subcutaneously in the morning (within 1–2 hours of waking), 3–5 times per week.

Human data exist primarily in sarcoidosis and chronic inflammatory response syndrome, where VIP shifts inflammatory markers and produces symptomatic improvement.¹⁷ The circadian role is extrapolated from established SCN physiology — well-characterised mechanism, sparse human circadian data.

Selank — Anxiety Gate

Selank is a synthetic analogue of the immune peptide tuftsin with documented anxiety-reducing effects. In clinical trials for generalised anxiety disorder, Selank produced effects comparable to benzodiazepines without sedation or dependence (GABA receptor modulation, serotonergic signalling²⁰˒²¹˒²³).

Dosed in the evening (~18:00–20:00), Selank reduces the rumination and late cortisol surges that block the clock's sleep descent signal. It does not induce sleep. It removes the interference that prevents it. For the full pharmacology, see the Selank guide. Its neuroprotective counterpart Semax addresses cognitive restoration through a different mechanism.

DSIP — Sleep Architecture

DSIP (delta sleep-inducing peptide) is a naturally occurring nonapeptide that biases the brain toward slow-wave sleep without sedation. Where conventional sleep drugs override the brain's inhibitory signalling to force unconsciousness, DSIP lowers the arousal threshold — the brain transitions into natural sleep descent rather than being overridden into it (GABAergic modulation⁶).

Research protocols describe 100–300 mcg subcutaneously, 30–60 minutes before bed, 3–5 nights per week during a defined 2–3 week course.⁶˒⁷ Diminishing returns are reported with extended continuous use.

Human data derive from small trials and observational series, mostly in insomnia and chronic pain, with mixed quality.⁶˒⁷ Mechanistic work is older, primarily from the 1980s and 1990s. The safety profile appears benign at research doses — no dependency, tolerance, or serious adverse events — but long-term continuous use is not well characterised.

Pinealon — Neural Infrastructure

Pinealon (EDR tripeptide) operates at the neuronal level — penetrating cell and nuclear membranes to strengthen the antioxidant defences and survival pathways of the neural tissue that supports circadian function (SOD2/GPX1 upregulation, caspase-3/p53 reduction¹⁵). In an Alzheimer's disease model, Pinealon maintained neuronal functional activity and reduced programmed cell death.¹⁵

Its role in this stack is not acute sleep modification. It is long-horizon protection of the cortical and pineal tissue that the other three compounds depend on — maintenance of the hardware the clock runs on.

Research protocols describe 0.5–1.0 mg subcutaneously daily for 10–20 days, repeated 1–2 times per year.¹² Pinealon has reported oral bioavailability — 0.2 mg twice daily for 20–30 days showed cognitive improvements in a clinical trial of 72 patients with cerebral asthenia.¹²˒¹⁵ Most data are preclinical or from small Russian clinical series.

Adequate NAD+

The circadian clock runs on a self-fuelling cycle: clock genes drive production of NAD+, and NAD+ powers the repair enzyme that resets the clock for the next day (SIRT1-NAD+ feedback loop¹˒¹⁰). When NAD+ pools are depleted, the clock weakens — not because the oscillator is broken, but because the fuel supply that powers it has thinned.

Adequate NAD+ is a prerequisite for clock function, not a circadian compound per se. The NAD+ guide covers the full evidence for restoration.

Clock Hardening — Epitalon

Epitalon (AEDG tetrapeptide) targets the rate-limiting enzyme in the melatonin production chain — restoring the pineal gland's capacity to produce melatonin rather than replacing its output (AANAT activation⁸). In aged primates, Epitalon increased nighttime melatonin 1.6-fold in subjects with pineal insufficiency but had no significant effect on young animals with normal output — consistent with a regulatory mechanism that restores declining function rather than pushing normal function higher.⁸

Research protocols describe 5–10 mg daily subcutaneously for 10–20 consecutive days, repeated 1–2 times per year with a 4–6 month washout.⁸˒¹² Evening administration aligns with circadian melatonin synthesis.

A 2025 Brunel University study provided the first independent Western validation of Epitalon's telomerase activation, with a notable finding: Epitalon behaves differently in normal cells versus cancer cells.⁹ See the Epitalon guide for the full telomerase evidence, the Khavinson question (single-source human outcome data), and FDA Category 2 status.¹³˒¹⁴

The 24-Hour Timing Map

Selank and DSIP form the nightly rhythm — evening gate opening followed by nighttime architecture deepening. VIP reinforces the morning peak independently. Pinealon and Epitalon run as periodic courses, not daily.

For general principles on combining peptides across axes, see the peptide stacking guide.

Evidence Hierarchy

The field needs independent multi-centre human trials for Epitalon health outcomes, well-powered sleep architecture studies for DSIP using modern polysomnography, and rigorous English-language safety studies for Pinealon.

FAQ

References

[1] Jung HY, Ahmad N. "Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer." J Pineal Res. 2010. PMC2948667.

[2] Duffy JF, Czeisler CA. "Effect of Light on Human Circadian Physiology." Sleep Med Clin. 2009;4(2):165-177. PMC2717723.

[3] Wehrens SMT, et al. "Meal Timing Regulates the Human Circadian System." Curr Biol. 2017;27(12):1768-1775. PMID 28578930.

[4] Eastman CI, Burgess HJ. "How To Travel the World Without Jet Lag." Sleep Med Clin. 2009;4(2):241-255. PMC2829880.

[5] Zhang Y, et al. "BMAL1 in Cellular Senescence and Age-Related Diseases." Front Endocrinol. 2022. PMC9207346.

[6] Schneider-Helmert D, Schoenenberger GA. "The influence of synthetic DSIP on disturbed human sleep." Experientia. 1983;39(1):53-55. PMID 1299794.

[7] Kovalzon VM. "Delta Sleep-Inducing Peptide (DSIP): an update." Eur J Anaesthesiol. 2001;18(7):419-422.

[8] Araj K, et al. "Overview of Epitalon -- Highly Bioactive Pineal Tetrapeptide." Int J Mol Sci. 2025. PMC11943447.

[9] Al-dulaimi O, et al. "Epitalon increases telomere length in human cell lines through telomerase and ALT activation." Biogerontology. 2025. PMC12411320.

[10] Nakahata Y, et al. "The NAD+-Dependent Deacetylase SIRT1 Modulates CLOCK-Mediated Chromatin Remodeling and Circadian Control." Cell. 2008;134(2):329-340. PMID 18662547.

[11] Chen WD, et al. "Circadian CLOCK Mediates Activation of Transforming Growth Factor-beta Signaling and Renal Fibrosis through Cyclooxygenase 2." Am J Pathol. 2015;185(12):3152-3163. PMID 25109806.

[12] Multiple sources consolidated. See: Khavinson VK. "Peptides of Pineal Gland and Thymus Prolong Human Life." Neuroendocrinol Lett. 2003;24(3/4):233-240. PMID 14523363. Protocol concordance confirmed across PMC11943447, practitioner documentation.

[13] FDA Interim Policy on Compounding Using Bulk Drug Substances (2023-2025). Category 2 designation for Epitalon. See also: Innerbody Research. "Epitalon Peptide: Benefits, Safety & Buying Advice." 2026.

[14] Khavinson VK, Morozov VG. "Peptides of pineal gland and thymus prolong human life." Neuroendocrinol Lett. 2003;24(3/4):233-240. PMID 14523363.

[15] Khavinson VK, et al. "EDR Peptide: Mechanism in Alzheimer's Pathogenesis." Molecules. 2020. PMC7795577.

[16] Vosko AM, et al. "Vasoactive intestinal peptide and the mammalian circadian system." Gen Comp Endocrinol. 2007;152(2-3):165-175.

[17] Gonzalez-Rey E, et al. "Vasoactive intestinal peptide in IBD pathogenesis." J Mol Med. 2020. PMC7789055. See also: PMID 20442436 (VIP immunoregulatory, sarcoidosis).

[18] Covarrubias AJ, et al. "NAD+ metabolism and its roles in cellular processes during ageing." Nat Rev Mol Cell Biol. 2021;22:119-141. PMC7963035.

[20] Zozulia AA, et al. "Efficacy and tolerability of Selank in patients with generalized anxiety disorder." Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(4):38-48. PMID 18454096.

[21] Medvedev VE, et al. "Selank in patients with anxiety-asthenic disorders." Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(6):17-22. PMID 25176261.

[23] Kudelin NV, et al. "Selank and GABA receptor gene expression." Bull Exp Biol Med. 2014. PMC4757669.

This content is for educational purposes only. Peptides discussed here are investigational compounds. Consult a physician before beginning any peptide protocol, particularly if you have active cancer, autoimmune conditions, or are taking medications that affect immune function or coagulation.